Issuer state, before the event · financials as of 2026-07-31
Amgen
Profile
- CIK
- 0000318154
- SIC
- 2836
- Sector (engine map)
- Pharma and devices Derived
- Reportable segments
- 1 Verified
- Fiscal period
- FY2025
- Financials as of
- last 10-K before 2026-07-31
- Ratio table
- Standard (default) internal calibration
Source documents
- XBRL company facts0000318154-26-000010
- Form 10-K FY20250000318154-26-000010
- Form 8-K Item 1.052026-07-31
Financial context, FY2025 (USD m)
As-reported proxies. S&P adjustments not applied.
DerivedVerified
| Metric | USD m | Provenance | XBRL tags or formula |
|---|---|---|---|
| EBITDA | 14,247Derived | Derived | OperatingIncomeLoss + DepreciationDepletionAndAmortization |
| Debt | 54,604Derived | Derived | CommercialPaper + LongTermDebtCurrent + LongTermDebtNoncurrent |
| FFO | 7,047Derived | Derived | OperatingIncomeLoss + DepreciationDepletionAndAmortization + InterestPaid + IncomeTaxesPaidNet |
| CFO | 9,958Verified | Verified | NetCashProvidedByUsedInOperatingActivities |
| FOCF | 8,100Derived | Derived | NetCashProvidedByUsedInOperatingActivities + PaymentsToAcquirePropertyPlantAndEquipment |
| DCF | 2,976Derived | Derived | NetCashProvidedByUsedInOperatingActivities + PaymentsToAcquirePropertyPlantAndEquipment + PaymentsOfDividendsCommonStock + PaymentsForRepurchaseOfCommonStock |
| Cash interest | 2,900Verified | Verified | InterestPaid |
| Operating leases (shown separately) | 831Verified | Verified | OperatingLeaseLiability |
Core ratios against S&P published bands
standard volatility table. Bands shown by numeric range.
FFO to debt12.9%Verifiedpre-event
In the 12% to 20% range. 7.5% above the next weaker boundary (12%), so borderline.
Debt to EBITDA3.83xVerifiedpre-event
In the 3x to 4x range. 4.2% below the next weaker boundary (4x), so borderline.
Pre-eventWithin 10% of a band boundary